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Abstract
High quality of care (QoC) for antiretroviral treatment (ART) is essential to prevent treatment fail-
ure. Uganda, as many sub-Saharan African countries, increased access to ART by decentralizing
provision to districts. However, little is known whether this rapid scale-up maintained high-quality
clinical services. We assess the quality of ART in the Acholi and Lango sub-regions of northern
Uganda to identify whether the technical quality of critical ART sub-system needs improvement.
We conducted a randomized cross-sectional survey among health facilities (HF) in Acholi (n¼11)
and Lango (n¼ 10). Applying lot quality assurance sampling principles with a rapid health facility
assessment tool, we assessed ART services vis-a`-vis national treatment guidelines using 37 indica-
tors. We interviewed health workers (n¼ 21) using structured questionnaires, directly observed
clinical consultations (n¼ 126) and assessed HF infrastructure, human resources, medical supplies
and patient records in each health facility (n¼ 21). The district QoC performance standard was 80%
of HF had to comply with each guideline. Neither sub-region complied with treatment guidelines.
No HF displayed adequate: patient monitoring, physical examination, training, supervision and
regular monitoring of patients’ immunology. The full range of first and second line antiretroviral
(ARV) medication was not available in Acholi while Lango had sufficient stocks. Clinicians dis-
pensed available ARVs without benefit of physical examination or immunological monitoring.
Patients reported compliance with drug use (>80%). Patients’ knowledge of preventing HIV/AIDS
transmission concentrated on condom use; otherwise it was poor. The poor ART QoC in northern
Uganda raises major questions about ART quality although ARVs were dispensed. Poor clinical
care renders patients’ reports of treatment compliance as insufficient evidence that it takes place.
Further studies need to test patients’ immunological status and QoC in more regions of Uganda
and elsewhere in sub-Saharan Africa to identify topical and geographical areas which are priorities
for improving HIV care.
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Introduction
Uninterrupted access to treatment with high-quality clinical care is
essential for people living with HIV/AIDS (PLHA) to achieve good
health outcomes. On the one hand, a patient’s perceived quality of
care (QoC) (compassion, confidentiality, timeliness, communication
and information) is associated with adherence to treatment (Etienne
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et al., 2010) and hence, with avoidance of therapy failure and drug
resistance (Osterberg and Blaschke, 2005). On the other hand,
regular clinical and immunological assessment and taking relevant
treatment consequences is also crucial for reducing risk factors for
poor clinical outcomes. Accordingly, improved QoC for PLHA can
reduce related morbidity and mortality (Ahoua et al., 2009; Lawn
et al., 2010). Depending on the intensity of monitoring efforts and
the application of different lines of treatment approximately 2.4–3.5
million disability adjusted life years (DALYs) could be averted year-
ly by antiretroviral treatment (ART) in sub-Saharan Africa (Hogan
et al., 2005).
By 2014, Uganda achieved approximately 50% coverage with
treatment of eligible PLHA (World Health Organisation, 2003;
UNAIDS, 2014). Alongside the new eligibility criteria introduced in
2013/14 (Uganda Ministry of Health, 2013), including more
patients in the therapy scheme, the coverage is expected to have
dropped again afterwards. ART in sub-Saharan Africa demands
between $556 and $2010 per DALY averted depending on the effort
in clinical monitoring of patients and expenditure in different types
of antiretroviral medication (ARV) (Hogan et al., 2005; Mikkelsen
et al., 2017). The national health budget could only cover 12% of
Uganda’s expenses for HIV/AIDS programmes in 2012/13
(UNAIDS, 2015). Furthermore, ART care is supported by an esti-
mated one-third of all health system human resources (HR) (USAID,
2010). However, HR in Uganda’s health system are scarce; in 2013,
37% of posts were vacant (Ministry of Health, 2013); in northern
Uganda, 49% were vacant during 2012 (NUMAT, 2012). This
raises questions about whether quality of ART care (QoC) can be
obtained due to the immense caseload in addition to the HR crisis
and the enormous funding gap.
Although Uganda’s Ministry of Health prioritizes the strengthen-
ing of monitoring and evaluation of QoC for HIV/AIDS services
(Uganda AIDS Commission, 2011), few institutions measure quality
beyond service availability and outcome indicators (NUMAT, 2010,
2011, 2012; Ministry of Health, 2011b; Ministry of Health,
2012a,b). Data on relevant specific clinical practices influencing
patients’ outcomes are not available. Even international indicators
for quality ART care in low- and middle-income countries do not
include performance variables even though acknowledging the
importance of on-site QoC (Ahonkhai et al., 2012).
Our study seeks to address this information gap for patients on
ART through a QoC assessment in northern Uganda, which has a
serious scarcity of health workers (HW), and hence, is a location
where deficiencies in quality services might be more apparent than
elsewhere. The question we address is: what is the current QoC
received by ART patients when assessed using multiple standards of
care as stipulated in the national guidelines? The different technical
categories of the quality assessed allow to prioritize clinical and
geographic areas that score worse. The resulting information can
lead programme managers to invest resources in targeted strategies.
This result should lead to improved diagnostic and therapeutic
procedures, counselling and treatment outcomes, which potentially
include a reduced viral load and drug resistance among PLHA. This
innovative approach can be applied elsewhere in sub-Saharan
Africa.
Methods
The sampling frame for this study comprises ART health facilities (HF)
in two sub-regions of northern Uganda. During 2014, 80 HF provided
ART services in the Acholi sub-region; 64 in Lango. To assess routine
ART provision, only facilities attending at least 12 non-naive ART
patients per week were included in the sampling frame (Acholi:
N¼20; Lango: N¼21) (Ministry of Health, 2014). We stipulated
these inclusion criteria to permit the data collection to take place in 1
day and to prioritize facilities that see the largest number of patients.
This study therefore concerns HFs who regularly serve PLHA.
The Rapid Health Facility Assessment (R-HFA) tool we pre-
tested in eastern Uganda in 2011 (Deurman, 2011), and refined in
2014 is attached as Supplementary data. The instrument comprised
five modules: direct observation of the clinical consultation; patient
interview; clinical documentation; checklist of drugs, laboratory and
other equipment; and HW interview. Data from those modules
measured 37 indicators/guidelines. The structure and protocol for
this R-HFA were adapted from a version developed for assessing
clinical services for sick children (Oladele et al., 2012; Berendes
et al., 2014) to which a co-author contributed (www.mchip.net/tech
nical-resource/the-rapid-health-facility-assessment-r-hfa/).
We applied lot quality assurance sampling (LQAS) principles to
calculate sub-regional random sample sizes. LQAS does not calcu-
late a precise prevalence or coverage measure of QoC or other
attributes (Robertson et al., 1997b) but uses binomial probabilities
to determine the probability a target prevalence for a certain charac-
teristic in a defined population has not been reached. For this pur-
pose, LQAS is quite robust (Pagano and Valadez, 2010). With this
information, policy and decision-makers identify priority geograph-
ical and technical areas for corrective action and to apportion
resources accordingly (Robertson et al., 1997a; Brooker et al.,
2005).
We also adapted the protocol used successfully for assessing the
QoC of maternal and child health services (Oladele et al., 2012;
Berendes et al., 2014) to this assessment of ART services, and con-
tinued to use as the standard that 80% of facilities of one sub-region
needed to comply with the national guidelines for ART services for
a sub-region to be classified as reaching an acceptable QoC. In
LQAS parlance, this target is referred to as an upper threshold (pU).
The 80% target was measured separately for each of the 37 indica-
tors. Simultaneously, we set a lower threshold (pL) to identify sub-
regions with very low QoC for these indicators. Typically, pL is 30
percentage points below pU (pL ¼ 50%).
The binomial model is often used to calculate LQAS cut-off val-
ues and errors to assess coverage in populations. However, HF
Key Messages
• Uganda’s low-quality clinical care for antiretroviral therapy raises worries about it compromising patients’ immunologic-
al status and drug resistance developing.
• Policies aimed at scaling up effective therapies need to be accompanied by keen assessment and improvement meas-
ures of the quality of clinical care.
• Direct observation of health services produced greater insight about the quality of care than patient records and service
availability reports.
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assessments typically have sampling frames with smaller numbers of
elements and require a finite population correction to calculate the
cut-off values: we used the above LQAS parameters in the hypergeo-
metric model (Valadez, 1991) to calculate HF sample sizes and
cut-off values (d) to classify the sub-regions such that a and b errors
(the risk of wrongly classifying a sub-region as not reaching the
quality threshold and vice versa) did not exceed 0.10. Cut-off values
are the minimal number of individuals in the sample that must have
the trait of interest for the lot (or sub-region) to be accepted.
Otherwise it is classified as failing to reach the target. Sub-regions
with performance between pU and pL had a probability of classifica-
tion associated with its proximity to either threshold. The resulting
sample sizes, cut-off values and error terms were: Acholi: n¼11,
cut-off¼8, a¼0.055, b¼0.064; Lango: n¼10, cut-off¼7, a
¼0.049, b ¼0.095 (Table 1). Each indicator we measured separ-
ately and applied LQAS principles to assess its performance in the
sub-region using these parameters.
For a health facility to meet the required standard of quality
for clinical performance, clinical behaviour had to be consistent with
the national guidelines 95% of the time (pu¼0.95). We assumed that
clinical performance is bimodally distributed: clinicians know the
proper technique and use it, or they are ignorant of it and therefore do
not. For this assessment, we therefore use a wider range to separate pU
and pL. The resulting parameters we used were pU¼95%, pL¼50%,
n¼6, cut-off¼5, a¼0.033 and b¼0.109. Therefore, clinicians
had to act correctly for each guideline in five out of six cases for
the HF to be classified as having an acceptable QoC (Valadez, 1991).
For the observation of clinical performance, we sampled the
most experienced clinician on the day of the visit to observe his/her
assessment of six adults who had been on ART for at least 6 months.
This approach provides results for a best-case scenario. Sampling
less experienced clinicians was expected to result in lower perform-
ance. We excluded children as paediatric treatment guidelines differ
substantially from those for adults (Ministry of Health, 2011a).
HFs in both sub-regions were randomly selected without
replacement. We sampled six patients per facility on a first come,
first served basis assuming patients arrived randomly at HF; also our
assessments took place at different times of the day. After informed
consent, the same six patients per facility were interviewed, their
reports checked and their clinical visits observed.
We pretested and refined the R-HFA tool May 13–14, 2015,
followed by a 2-day training of the data collection team; all enumer-
ators had a professional clinical background. Data collection took
place from May 18 to June 17, 2015. All completed R-HFA tools
were cross-checked by one of the co-authors for logical errors and
inconsistencies and corrected with the enumerator when necessary;
the data were then entered and cleaned from June 18 to July 10,
2015. For the LQAS classification analysis, we used Microsoft Excel
2010, and SPSS V22 for all other analyses.
This study was reviewed and approved by the authors’ institutes.
Results
Of the HF sampled in Acholi (n¼11) two were hospitals, six Health
Centres (HC)-IV and three HC-IIIs; in Lango (n¼10) three were
hospitals, four HC-IVs and three HC-IIIs. Our sample included
both high- and low-volume HF with patient numbers ranging from
15 to 400 per day. The mean consultation duration in both Acholi
and Lango was 9 min (range: Acholi 3–22 min, SD¼4.3; Lango
2–28 min, SD¼5.2; median¼8 min in both sub-regions). Three
outliers (one in Acholi: 52 min; two in Lango: 34 and 48 min) were
excluded because the patients waited for laboratory results before being
discharged and the clinician attended other patients in the meanwhile.
Compliance with the national guidelines was low in both
sub-regions. For only 43.2% of the 37 guideline indicators measured
did Acholi reach the 80% standard of performance. Lango was clas-
sified adequate for only 37.8% of the indicators. The guidelines’
indicators are categorized as Input, Performance, Outcome and
Patient Management. The pattern of compliance with the guidelines
shows little difference across the two sub-regions (Table 2).
Inputs
In addition to the shortage of HW, their training and supervision
was problematic: Only two of the sampled facilities in Acholi
and five in Lango had staff with accredited pre-service training for
treating PLHA which is below the cut-off value of d¼8. In-service
training did not take place in any sampled facility nor did regular
supervision; only one HF in Acholi and two in Lango reported
supervision meetings. However, all HW could indicate a contact
person to discuss or refer difficult cases, which indicates functional
management support.
We detected problems with the supply chain in Acholi. The es-
sential first and second line ARV combinations (according to the na-
tional ARV guidelines) are: (first line) TDF/3TC, AZT/3TC, ABC/
3TC, NVP, EFV, and (second line) ATV/r, LPV/r. Acholi failed for
these provisions as the only consistently available drug combination
was AZT/3TC. Lango did not exhibit this problem. However,
patients in both sub-regions had access to their prescribed ARV
combination which was AZT/3TC. Whether or not this treatment
was the appropriate medication for the patient based on his/her clin-
ical and immunological status stays unclear as neither the clinical
nor the immunological monitoring took place.
Both sub-regions failed to reach the standard for the availability
of the essential anti-opportunistic drugs. Nystatin and Dapson were
available in <50% of the assessed facilities in Acholi, and Lango
was below the threshold in Nystatin availability. Cotrimoxazole
was the sole anti-opportunistic drug in adequate supply and the only
one prescribed by HW in both regions.
As PLHA need to be monitored and managed for any (infectious)
disease more closely than other patients, their access to drugs besides
ARVs is also crucial. When assessing access to other drugs, Lango
Table 1 Sample size, decision rule and classification errors for Acholi, Lango and northern Uganda
Sub-region No. eligible HF (No.)a pU pL Sample Size (n) Decision Rule (d) a error b error
Acholi (original sample) 20 0.8 0.5 10 7 0.043 0.089
Acholi (additional facility added)a 20 0.8 0.5 11 8 0.068 0.035
Lango 21 0.8 0.5 10 7 0.049 0.095
aIn Acholi, we included one additional HF as a contingency in case of locating an inaccessible HF the resulting data were included in the analysis (see Acholi—
additional facility added).
HF, health facilities.
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failed mainly due to the lack of analgesic drugs, but also for different
anti-infective medications (e.g. antifungals, anthelmintic and anti-
biotic drugs). Acholi was not deficient in the latter medications.
Laboratories satisfied the basic requirements for monitoring
PLHA (referral system or equipment complete). However, the
availability of equipment needed to clinically monitor patients on
ART (e.g. stethoscope, sphygmomanometer and the like) was inad-
equate in both sub-regions and the use of the laboratory or referral
system for patient monitoring was near to zero (see below and
Table 2).
Table 2 Health facility classifications for input, performance, outcome and patient management indicators or antiretroviral therapy
provision
No. Indicator label Tool Acholi (n ¼ 11, d ¼ 8) Lango (n ¼ 10, d ¼ 7)
Input
1a Pre-service training HWI 2 5
1b In-service training HWI 0 0
2 Supervision HWI 1 2
3 Laboratory supply (on site or referral system in place) HFC 10 8
4 Equipment HFC 6 4
5ARV1 ARV availability first line (all essential combinations available) HFC 6 7
5ARV2 ARV availability second line (all essential combinations available) HFC 7 10
5TB TB drug availability (all essential drugs available) HFC 4 2
5OPP Anti-opportunistic drug availability (all essential drugs available) HFC 4 3
5FP Family planning availability HFC 5 6
6ARV Access to ARV (prescribed drugs available) PI 11 10
6OPP Access to anti-opportunistic infection drugs (prescribed drugs available) PI 11 10
6Oth Access to other medication (prescribed drugs available) PI 9 5
Performance
7a History taking: current well-being Obs 11 9
7b History taking: hospitalization, changes Obs 4 4
7c History taking: TB screen Obs 5 7
7d History taking: symptom checklist Obs 0 0
8 Physical examination Obs 0 0
9a Treatment: consistent with HW diagnosis Obs 9 5
9b Treatment: consistent with history and examination Obs 3 1
10a Counselling: adherence strategies Obs 7 6
10b Counselling: transmission of HIV Obs 3 0
10c Counselling: family testing Obs 2 0
10d Counselling: medication use Obs 8 5
Outcome
11a Patient perception: history PI 10 9
11b Patient perception: examination PI 6 4
12 Patient knowledge: medication PI 11 10
13 Patient’s adherence to medication PI 10 8
14 Disclosure of the status to partner PI 11 9
15 Family testing for HIV PI 10 6
16 Patient knowledge: HIV PI 0 0
Patient management
17 CD4-monitoring (last CD4-count not older than 9 months) PR 2 1
18 ART Initiation PR 8 5
19a ART documentation: TB screen PR 11 9
19b ART documentation: treatment regimen PR 11 10
19c ART documentation: counselling PR 2 0
20 Follow-up PR 9 8
¼ failure of a sub-region for that indicator, ¼ success of a sub-region for that indicator. The sub-regions were appraised according to the upper and
lower threshold (pU¼ 80%, pL¼ 50%, Acholi: N¼ 20, n¼ 11, d¼ 8; Lango: N¼ 21, n¼ 10, d¼ 7).
HWI, health worker interview; PI, patient interview; Obs, observation of the clinical visit; PR, patients’ records.
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Performance
While clinicians dispensed to patients ARVs and other drugs, a com-
plete patient history (e.g. recording symptoms/danger signs as sug-
gested by the national ART guidelines) and a physical examination
were not taken in any of the assessed HF. Even patients with com-
plaints were not examined in most cases. Patients without explicitly
stated problems were not checked at all. An attempt to detect
(asymptomatic) danger signs on an early and regular basis did not
take place. Table 2 shows four categories of essential history taking
as per the ART guidelines and the results for each sub-region.
Furthermore, the treatment of symptomatic patients was problem-
atic. Diagnoses were taken without sufficient patient history or physic-
al examination in either sub-region. In addition, HW in Lango
deviated from their noted diagnosis when prescribing medicine. This
result raises the possibility of the improper use of medications. Also, in
regards to the patient counselling, both sub-regions failed (Table 2).
Outcome
Patients’ knowledge about HIV transmission was inadequate in all
facilities. Ugandan guidelines require counselling all HIV patients on
six ways to avoid the transmission of HIV: abstinence, faithfulness,
condom use, consequent treatment with ART, use of ART to pre-
vent transmission of HIV from mother to child during delivery and
no sharing of sharps.
An average patient in Acholi could recall 2.6 of 6 HIV transmis-
sion pathways, and 2.3 in Lango. The predominant area of know-
ledge about HIV prevention in both regions was condom use. ‘No
sharing of sharps’ was known in Acholi.
All patients knew correctly when and how to take the prescribed
drugs. In both sub-regions, an adequate number of patients indi-
cated adherence to treatment and disclosure of their status to their
partners. In contrast to Acholi, Lango failed for HIV testing for all
or most of the family members. Even though history taking was
done poorly, patients felt sufficiently comfortable with it in each
sub-region. However, patients’ in both sub-regions also felt their
physical examination was inadequate; this finding is consistent with
our own conclusion based on direct observation.
Patient management
Even though 7 of the 11 assessed HF in Acholi and 6 out of 10 in
Lango had functioning laboratory equipment and relevant reagents
for a CD4-count available on the day of visit, almost none of them ac-
tually did so. HF without an on-site testing capability did not monitor
patients’ CD4-counts at all, despite having a functioning referral sys-
tem in place. Therefore, even though the indicator for laboratory sup-
ply (meaning on-site measurement or referral system in place) met the
target, both sub-regions failed to monitor CD4-counts.
Both regions did achieve the standard for clinical TB screening
when using the information available on patient records. However,
our direct observation failed to confirm adequate clinical TB screen-
ing in Acholi; nevertheless, Lango continued to meet the 80% target.
Both sub-regions failed for almost all aspects of counselling (i.e. ad-
herence strategies, transmission of HIV, family testing) with the ex-
ception of counselling about drug administration in Acholi, which
met the target. Also, both sub-regions failed for documentation of
counselling (Table 2).
Discussion
This cross-sectional health facility assessment survey in two north-
ern Ugandan sub-regions evaluated the QoC for non-naı¨ve ART
patients and showed poor results in all indicator categories. These
results suggest that Acholi and Lango are sub-regions needing add-
itional support to improve the health systems leading to effective
ART care. Other regions where we carried out the pre-test of the R-
HFA, reported similar challenges (Deurman, 2011). Additional com-
parable assessments are now needed in Uganda to identify other geo-
graphical and technical areas in need of priority support. These
results also suggest the need for QoC assessments elsewhere in sub-
Saharan Africa.
Our assessment revealed discrepancies between the availability
of the printed documentation and direct observation of perform-
ance. Observation of counselling in Acholi exhibited better perform-
ance, than the availability of documentation of counselling
guidelines which failed to reach the national quality standard.
However, while the documentation of TB screening reached the
standard in both sub-regions, direct observation data indicated that
Acholi failed to meet the standard for clinical performance. This dis-
crepancy is in accordance with other studies (Edwards et al., 2014).
Appraisals using direct observation for child health care identified
poor clinical performance, and noted discrepancies between
reported and observed health care (Oladele et al., 2012; Berendes
et al., 2014). Although the availability of quality documentation of
clinical performance is widely seen as an indicator of good QoC, the
use documentation can be hampered by high workload and/or com-
plicated documentation regulations (Shihundla et al., 2016). The
QoC described and evaluated by examining documentation only,
might lead to false-positive and/or false-negative results.
Similarly, the availability of services did not ensure their use.
Regular immunological monitoring failed in both sub-regions, even
though functioning equipment for monitoring was available in twice
as many HF as those which failed; the other HFs reported a referral
system in place although there is no evidence it was used sufficiently.
More than 80% of HF could have carried out immunological moni-
toring (on-site or by referral) but did not do so. Hence, health sys-
tem managers should not infer that the availability of a service leads
to its correct and regular use. Data about available services at the
HF level are not sufficient for making conclusions about QoC.
Another discrepancy we detected was the availability of ARVs
and essential drugs to treat opportunistic infections. Acholi exhib-
ited insufficient availability of ARVs in their supplies and stocked
only one ARV combination sufficiently. Lango did not have this
problem. However, clinicians in both sub-regions dispense the
ARVs they had on hand without the benefit of giving a physical
examination or monitoring immunological status.
A similar pattern was observed for the availability of essential
anti-opportunistic infection drugs and other medications in Acholi.
Both sub-regions failed for having the essential drugs as required by
the national ARV guidelines, and again clinicians tended to dispense
drugs that were available such as Cotrimoxazole (see Table 2). This
might be a sign of a long-term supply chain problem, or HW could
have grown accustomed to the absence of drugs and therefore
tended to offer patients the available medication rather than the
most appropriate therapy. This practice is described by other studies
(Minior et al., 2017). We can report that only three institutions in
Acholi and one in Lango treated patients in accordance with clinical
findings. As the appraisal of individual symptoms and the resulting
treatment were not the main interests of our assessment, the study
design does not allow us to make generalizations about this practice.
Clinical observation at a regional or nationwide level can be ex-
pensive and time consuming. Most QoC assessments, therefore, rely
on input indicators and documentation only. However, the failure in
using available technology and the discrepancies we detected leave
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questions about whether QoC can be sufficiently evaluated by
counting the availability of documentation and service availability
only. The method we used is field friendly, and time and HR effi-
cient, and not costly. We assessed up to two HF in one working day.
This is the same time expenditure for a team using WHO’s SARA
tool (World Health Organisation, 2013) which does not include
clinical observation which proved to be very insightful. Other HFA
that include interaction with providers and patients and/or direct
observation (HRHS, HFA) do consume more time per team (1–
2 days per facility) (Hozumi et al., 2006).
We examined QoC in reference to the national ART guidelines;
as a result, the international standards were not included in the tool.
This deficiency may limit the comparisons of this study with other
settings. We also recognize that direct observation of clinical care
may have produced a Hawthorne effect, although other studies of
this effect have shown no to little impact of direct observation on
improving results (McCambridge et al., 2014; Goodwin et al., 2017).
Nevertheless, in our study should it exist, the Hawthorne effect may
be an advantage. If our results record the best-case scenario then clin-
ical performance without direct observation could be even worse.
The outcome indicators we used did not reflect the deficiencies
in inputs and processes; patients were sufficiently content with his-
tory taking, knew when and how to take their drugs, and stated they
took their medication. Reports from north-western Uganda (Ahoua
et al., 2009) revealed 8% of treatment failure after 1-year on ART
and 38% after 2-years on ART; among the treatment failures, 7%
(after 1-year) and 13% (after 2-years) showed a resistant virus.
Extrapolating those findings to our study clientele suggests that our
outcome indicators are incomplete, and underlines the priority of
regular immunological monitoring.
The discrepancies between the reported and the observed QoC
were surprising. The comparison was between reaching the 80%
cut-off for one indicator and failing the cut-off for the counterpart
observing indicator (or vice versa). Such results suggest that more
in-depth mixed methods approaches might be needed to provide
additional insight into the supply chain and prescribing practices we
have noted.
In the light of the overall poor-quality health care for ART
patients and the detected discrepancies, we recommend to further
QoC studies of HIV services that include direct observation and im-
munological monitoring. The extent and impact of the deficiencies
in quality on the patients’ status and outcomes need to be assessed
and addressed. More regions should be involved in the sampling
frame to see whether the northern Ugandan sub-regions are priority
areas for technical assistance in HIV care or whether the QoC defi-
ciencies is a wider spread problem throughout Uganda. Such imple-
mentation research should also take place elsewhere in sub-Saharan
Africa, as well as accompanying studies of ARV resistance.
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